Acadian Asset Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-1,756,129
| Closed | -$19.3M | – | 1640 |
|
|
2017
Q2 | $19.3M | Sell |
1,756,129
-26,610
| -1% | -$293K | 0.09% | 209 |
|
|
2017
Q1 | $17.5M | Sell |
1,782,739
-136,433
| -7% | -$1.34M | 0.08% | 218 |
|
|
2016
Q4 | $20.7M | Sell |
1,919,172
-65,850
| -3% | -$711K | 0.1% | 189 |
|
|
2016
Q3 | $20.3M | Sell |
1,985,022
-397
| -0% | -$4.07K | 0.1% | 185 |
|
|
2016
Q2 | $25.9M | Sell |
1,985,419
-3,706
| -0.2% | -$48.4K | 0.13% | 154 |
|
|
2016
Q1 | $21.9M | Buy |
1,989,125
+31,595
| +2% | +$348K | 0.11% | 192 |
|
|
2015
Q4 | $18M | Buy |
1,957,530
+113,502
| +6% | +$1.04M | 0.09% | 217 |
|
|
2015
Q3 | $12.8M | Sell |
1,844,028
-94,800
| -5% | -$658K | 0.07% | 246 |
|
|
2015
Q2 | $19M | Sell |
1,938,828
-54,831
| -3% | -$538K | 0.09% | 202 |
|
|
2015
Q1 | $17.7M | Sell |
1,993,659
-31,295
| -2% | -$277K | 0.08% | 219 |
|
|
2014
Q4 | $17.7M | Buy |
2,024,954
+33,244
| +2% | +$291K | 0.08% | 217 |
|
|
2014
Q3 | $13.7M | Buy |
1,991,710
+760,575
| +62% | +$5.24M | 0.07% | 243 |
|
|
2014
Q2 | $6.48M | Buy |
1,231,135
+236,029
| +24% | +$1.24M | 0.03% | 332 |
|
|
2014
Q1 | $4.53M | Sell |
995,106
-222,714
| -18% | -$1.01M | 0.02% | 345 |
|
|
2013
Q4 | $6.14M | Sell |
1,217,820
-131,018
| -10% | -$660K | 0.03% | 311 |
|
|
2013
Q3 | $6.84M | Buy |
1,348,838
+754,675
| +127% | +$3.83M | 0.04% | 278 |
|
|
2013
Q2 | $2.95M | Buy |
+594,163
| New | +$2.95M | 0.02% | 350 |
|